CrushSCI.com
Journal Selection & Manuscript Polishing Services
LABORATORY INVESTIGATION journal cover Medicine
Back to journal directory

Review Cycle Records

LABORATORY INVESTIGATION

Elsevier SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
150.7Average days
139Median days
38Fastest days
308Longest days
1,9932025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

308 days

Tumor Immune Microenvironment and Clinicopathological Characteristics of Thoracic NUT Carcinoma

AuthorsKeke Wang; Xu Cai; Chunyan Wu; Yan Huang; Xiaoyan Chen; Shenglei Li; Jiansha Li; Yan Li; Li Gong; Xiaorong Mu; Xinyue Zhang; Guangjian Yang; Yuan Li

AffiliationsDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Pathology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China; Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Pathology, Tangdu Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, China; Department of Pathology, Union Hospital, Fujian Medical University, Fuzhou, China; Department of Respiratory Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Source PDF DOI Publisher page
161 days

Tumor-Infiltrating Basophils Are Associated With Improved Prognosis in Colorectal Cancer

AuthorsOskari Rahkola; Henna Karjalainen; Ville K. Äijälä; Meeri Kastinen; Vilja V. Tapiainen; Hanna Elomaa; Onni Sirkiä; Vesa-Matti Pohjanen; Maarit Ahtiainen; Olli Helminen; Taneli T. Mattila; Outi Lindgren; Erkki-Ville Wirta; Jukka Rintala; Sanna Meriläinen; Juha Saarnio; Tero Rautio; Toni T. Seppälä; Jan Böhm; Jukka-Pekka Mecklin; Anne Tuomisto; Markus J. Mäkinen; Juha P. Väyrynen; Päivi Sirniö

AffiliationsTranslational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland; Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland; Central Finland Biobank, Hospital Nova of Central Finland, Well Being Services County of Central Finland, Jyvaskyla, Finland; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland; Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland; Applied Tumor Genomics, Research Program Unit, University of Helsinki, Helsinki, Finland; Department of Pathology, Hospital Nova of Central Finland, Well Being Services County of Central Finland, Jyvaskyla, Finland; Department of Education and Research, Well Being Services County of Central Finland, Jyvaskyla, Finland; Faculty of Sport and Health Sciences, University of Jyväskylä, Jyvaskyla, Finland

Source PDF DOI Publisher page
99 days

Genome-Wide Single-Nucleotide Polymorphism (SNP)-based Profiling of Loss of Heterozygosity Reveals Distinct Molecular Subgroup-Specific Patterns in Gastrointestinal Stromal Tumors (GIST)

AuthorsThais Maloberti; Margherita Nannini; Annalisa Astolfi; Maria Concetta Nigro; Livia Gozzellino; Alice Costa; Maria Giulia Pirini; Antonio De Leo; Marco Grillini; Bruno Vincenzi; Elena Fumagalli; Antonella Brunello; Giovanni Grignani; Sandra Aliberti; Angela Dalia Ricci; Fabio Gelsomino; Giovanni Tallini; Maria Abbondanza Pantaleo; Dario de Biase

AffiliationsSolid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy; Medical Oncology Unit 2, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy; Department of Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy; Candiolo Cancer Institute, FPO – IRCCS, Candiolo, Italy; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS “S. de Bellis” Research Hospital, Castellana Grotte, Italy; Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Modena, Italy; Department of Pharmacy and Biotechnology (FaBit), University of Bologna, Bologna, Italy

Source PDF DOI Publisher page
117 days

Assessing the Effects of a 3-Dimensional (3D) Pathology Tissue-Processing Workflow on Downstream Molecular Analyses

AuthorsElena Baraznenok; Huai-Ching Hsieh; Lydia Lan; Eric Q. Konnick; Sandy Figiel; Srinivasa R. Rao; Dan J. Woodcock; Ian G. Mills; Freddie C. Hamdy; Jacob E. Valk; Kelly T. Carter; Ming Yu; Thomas G. Paulson; Suzanne Dintzis; William M. Grady; Jonathan T.C. Liu

AffiliationsDepartment of Bioengineering, University of Washington, Seattle, Washington; Department of Mechanical Engineering, University of Washington, Seattle, Washington; Department of Bioengineering, University of California Berkeley, Berkeley, California; Department of Bioengineering, Stanford University, Stanford, California; Department of Pathology, Stanford University, Stanford, California; Department of Biology, University of Washington, Seattle, Washington; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington

Source PDF DOI Publisher page
308 days

Comparative Immune Profiling of Murine and Human Pancreatic Cancer Precursors Reveals Species- and Lesion-Dependent Immune Microenvironments

AuthorsLena Haeberle-Graser; Marie Schulte; Carolin Mueller; Sebastian Haensch; Martin Schlensog; Irene Esposito

AffiliationsInstitute of Pathology, Heinrich Heine University & University Hospital Duesseldorf, Germany; Barmherzige Brueder Hospital Regensburg, Department of Anesthesiology and Surgical Intensive Care Medicine, Germany; Department of Pediatrics, Helios Klinikum Krefeld, Academic Hospital RWTH Aachen, Germany; Center for Advanced Imaging (CAi), Heinrich Heine University Duesseldorf, Germany

Source PDF DOI Publisher page
38 days

Preanalytical Determinants of Patient Eligibility for Immune Checkpoint Inhibitors Revealed by Quantitative Programmed Cell Death Ligand-1 (PD-L1) Analysis

AuthorsAlessandro Gambella; Luca Mastracci; Chiara Trambaiolo; Luca Guastini; Michele Paudice; Simona Pigozzi; Silvia Bozzano; Valentina Angerilli; Alessandro Caputo; Paola Parente; Alessandro Vanoli; Matteo Fassan; Federica Grillo

AffiliationsDepartment of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy; IRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy; Pathology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Department of Otolaryngology and Head and Neck Surgery, IRCCS San Martino Polyclinic Hospital, Genoa, Italy; Surgical Pathology Unit, ULSS2 Marca Trevigiana, Treviso, Italy; Department of Pathology, University Hospital of Salerno, Salerno, Italy; Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Baronissi, Italy; Pathology Unit, Azienda Ospedaliero Universitaria Policlinico Foggia, Foggia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Unit of Anatomic Pathology, IRCCS San Matteo Hospital Foundation, Pavia, Italy; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; Department of Medicine (DIMED), University of Padua, Padua, Italy

Source PDF DOI Publisher page
72 days

Immunohistochemical Assay Variability and Human Epidermal Growth Factor Receptor 2 (HER2)-Low Breast Cancer Detection: A Laboratory Comparison in the Netherlands

AuthorsZeynep E. Kain; Emma Schuurman; Ximena Baez-Navarro; Henrik Høeg; Prasanth Kanneganti; Nils ’t Hart; Carolien H.M. van Deurzen

AffiliationsDepartment of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Pathology, Isala, Zwolle, the Netherlands; Visiopharm A/S, Hørsholm, Denmark; Boston Cell Standards Inc, Boston, Massachusetts

Source PDF DOI Publisher page
78 days

Paired Tissue and Circulating Tumor DNA Profiling Reveals Novel ESR1 Amplifications and CDK4/6 Inhibtor Resistance Mechanisms in Hormone Receptor–Positive/HER2–Negative Metastatic Breast Cancers

AuthorsLiu Liu; Stephanie L. Graff; Liang Cheng; Yihong Wang

AffiliationsDepartment of Pathology and Laboratory Medicine, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island; Division of Medical Oncology, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island

Source PDF DOI Publisher page
165 days

Cross-Platform Comparative Spatial Transcriptomics in High-Grade Serous Carcinoma

AuthorsOmar Youssef; Lars Selander; Shuyu Zheng; Lilla Csellar; Satu Hänninen; Jing Tang; Olli Carpén; Anna Ray Laury

AffiliationsDepartment of Pathology, University of Helsinki, Helsinki, Finland; Clinical and Chemical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; KIGene Core Facility, Karolinska Institutet, Stockholm, Sweden; Helsinki Biobank, Helsinki, Finland; University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Source PDF DOI Publisher page
161 days

Impact of Copy Number Alterations on Human Papillomavirus (HPV)–Induced and HPV–Independent Penile Cancers

AuthorsMikhail S. Ermakov; Sigrid Regauer; Karl Kashofer

AffiliationsDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.